Novo Nordisk’s stock slumps after failed trial — adding to the company’s woes

3 days ago 1
ARTICLE AD BOX
The Danish healthcare company’s stock slumped on Friday after it announced the Phase 3 trial failure.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Novo Nordisk’s stock slumps after failed trial — adding to the company’s woes

Related

HSBC quarterly profit soars to $10.1bn

HSBC quarterly profit soars to $10.1bn

1 hour ago 0
Revolut chief Nik Storonsky sued by broker over €350mn superyacht

Revolut chief Nik Storonsky sued by broker over €350mn super...

1 hour ago 0
‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

‘Arrogance kills’: Novo chief injects risk-taking into Ozemp...

1 hour ago 1
RIGHT SIDEBAR TOP AD

Trending

1. aaron farinacci spokane
2. mitch mcconnell
3. adam sandler
4. davante adams
5. the amazing spider-man
6. rihanna
7. oregon fires
8. jasson dominguez
9. eshop sale
10. harry truman

Popular

Netflix investors are getting squeamish as Amazon makes inroads in the battle for streaming dominance

Netflix investors are getting squeamish as Amazon makes inro...

1 month ago 7
Some singles now expect their dates to pay for their Ubers while gas prices are so high

Some singles now expect their dates to pay for their Ubers w...

1 month ago 5
Jane Street Plans New Data Center as Compute Power Runs Scarce

Jane Street Plans New Data Center as Compute Power Runs Scar...

1 month ago 5
‘This is not a flash in the pan’ — why value stocks are beating growth by such a wide margin

‘This is not a flash in the pan’ — why value stocks are beat...

1 month ago 5
Here’s how SpaceX is pitching its IPO to everyday investors

Here’s how SpaceX is pitching its IPO to everyday investors

1 month ago 4
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexus Financial News 2026. All rights are reserved